
Venture builder creating agricultural enterprises that raise incomes for smallholder farmers in sub-Saharan Africa

London-based group backing and growing science and technology companies in life sciences, deep tech and cleantech

Backing and growing businesses built on science and technology is what IP Group does, with the aim of generating financial returns alongside social and environmental impact. The firm describes its expertise in this area as deep, and it is a listed company with a portfolio that runs from early-stage to mature businesses.
The group runs HealthTech, DeepTech and CleanTech teams. Its HealthTech team works towards a healthier future by aiming to cure and prevent disease rather than only treating symptoms. Its DeepTech team invests in assets that enable digital resilience, prosperity and new human capability, targeting differentiated innovations that could disrupt large global markets. Its CleanTech team backs companies addressing the global climate challenge with scalable climate technology.
The group says its portfolio runs from early-stage businesses to mature ones, spanning life sciences, technology and cleantech with new commercial ideas. Its team has people from technology and life sciences, along with specialists in finance, investment, operations and hiring, and it is skilled at commercialising innovation. Portfolio companies it names include Istesso, which has started a Phase 2 clinical trial, Featurespace, First Light Fusion and Oxbotica.
Its ties run through UK universities, and it has partners in the United States, Australia and New Zealand. It describes its approach as open to the best science wherever it is developed, and it aims to bring that science into businesses that can reach markets.
The group has launched a Climate Catalyst Fund with Australia's Clean Energy Finance Corporation. The fund is designed to scale Australian technologies that can decarbonise hard-to-abate industries, and it reflects the group's commitment to climate solutions that work at scale.
The group says it aims to generate social and environmental impact alongside financial returns, and that its investments align closely with the UN Sustainable Development Goals. It describes its work as accelerating the impact of science, and it presents the portfolio as a way for shareholders to gain exposure to high-growth businesses in growth markets.
IP Group plc is a listed company that invests in and builds businesses based on science and technology. Its head office is at King's Cross in London, and its portfolio runs from early-stage to mature companies.
University spin-outs and early-stage companies, as well as shareholders who want exposure to that portfolio. Named holdings include Featurespace, First Light Fusion, Istesso, Oxford Nanopore Technologies and Oxbotica.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
No questions yet. Be the first to ask about IP Group.
Similar listings buyers compare against this one.

Venture builder creating agricultural enterprises that raise incomes for smallholder farmers in sub-Saharan Africa

Technology investor with separate arms for growth companies, venture funds and sport

New York City investor funding entrepreneurs who build a stronger, more inclusive local economy

Venture capital firm investing in early to growth-stage fintech companies through a network of banks

Investor in web3 businesses across crypto infrastructure, DeFi, digital assets and blockchain gaming

Investor putting funds into for-profit and non-profit projects that support inner growth and consciousness

Venture fund backed by a trading firm, investing in technical founders whose companies rely on machine learning

Early-stage venture fund and accelerator run by Jason Calacanis, backing startups with events, courses and a syndicate
Everything here links back to the same verified catalogue. Pick your next stop.